26.5 C
Dubai
Thursday, April 25, 2024
spot_img

Remedy Entertainment Oyj (HEL:REMEDY) just reported that analysts have been slashing their estimates

[ad_1]

shareholders may have noticed Remedy Entertainment Oyj (Help: Remedy) filed its annual results this time last week. Early reaction was not positive, with shares down 2.4 percent to 21.95 euros in the past week. Remedy Entertainment Oyj reported revenue of EUR 44 million, which was in line with expectations, but unfortunately it also reported a (statutory) loss of EUR 0.13 per share, slightly higher than expected. Analysts updated their earnings models based on the results, and it will be good to know whether they think the company’s outlook has changed dramatically, or it’s business as usual. We gathered the latest statutory forecasts to see if analysts have changed their earnings models based on these results.

Check out our latest analysis for Remedy Entertainment Oyj

HLSE: REMEDY Earnings and Income Growth February 15, 2023

Taking into account the latest results, the current consensus of three analysts from Remedy Entertainment Oyj is for 2023 revenue of €37.2 million, which would reflect a sharp 15% reduction in Remedy Entertainment Oyj’s sales over the past 12 months. Losses are expected to surge 422 percent to 0.67 euros per share. However, ahead of the latest earnings release, analysts had been forecasting a loss of 0.50 euros per share on revenue of 39.2 million euros in 2023. While revenue expectations for the year have fallen, expectations for loss per share have sadly increased, suggesting that the general consensus is that sentiment on the stock is a bit mixed.

The average price target remained largely unchanged at €27.50, perhaps suggesting that the weaker earnings outlook is not expected to have a long-term impact on valuations. It may also be instructive to look at the range of analyst estimates and assess how far outliers differ from the mean. Currently, the most bullish analysts value Remedy Entertainment Oyj at EUR 30.00 per share, while the most pessimistic value it at EUR 25.00. Still, with such a narrow valuation range, it suggests analysts have a pretty good idea of ​​what they think the company is worth.

Another way we look at these estimates is in the larger context, such as how the forecast compares to past performance and whether the forecast is more optimistic relative to other companies industry. These estimates imply that sales are expected to slow, with annualized revenue expected to decline by 15% by the end of 2023. This represents a significant decline from the annual growth rate of 22% over the past five years. Compare this to our data, which shows that, overall, other companies in the same industry are projected to grow their revenue by 6.9% per year. So while its revenue is expected to shrink, the cloud doesn’t offer a silver lining – with Remedy Entertainment Oyj expected to lag the broader industry.

the bottom line

Most notable is the forecast for increased losses next year, suggesting that it may not be all plain sailing for Remedy Entertainment Oyj. Unfortunately, they also lowered their revenue forecasts, which our data suggests are expected to underperform the industry as a whole. Even so, earnings per share are more important to the intrinsic value of a business. The consensus price target is steady at €27.50, with the latest estimates not enough to impact their price target.

Along this line of thinking, we believe the long-term prospects of the business are more important than next year’s earnings.We predict that Remedy Entertainment Oyj will last until 2025, you can Check them out for free on our platform.

Also, you should know 1 warning sign We discovered Remedy Entertainment Oyj .

Valuation is complicated, but we’re helping make it simple.

Find out if Remedy Entertainment Oyj is potentially overvalued or undervalued by reviewing our comprehensive analysis which includes Fair value estimates, risks and caveats, dividends, insider trading and financial health.

View free analysis

This article by Simply Wall St is general in nature. We use only an unbiased methodology to provide reviews based on historical data and analyst forecasts, and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take into account your objectives or your financial situation. Our goal is to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative material. Simply Wall St has no positions in any of the stocks mentioned.

[ad_2]

Source link

Related Articles

Akshay Kumar Set to Ignite Telugu Screens with Debut, Breaking Boundaries

Akshay Kumar Set to Blaze a Trail with Telugu Debut Alongside Prabhas and Mohanlal Excitement mounts in the world of cinema as Bollywood's beloved actor,...

Salim Khan Condemns Threats Against Son Salman Khan as ‘jaahil’, Assures Enhanced Police Protection by Eknath Shinde.

Salim Khan Speaks Out on Threats Against Son Salman Khan Amidst Recent Firing Incident Following a visit by Maharashtra Chief Minister Eknath Shinde to their...

Saisha Bhasin Khan Excited About Starring in Upcoming Netflix Feature Film “Perfect Dad”

Saisha Bhasin Khan Gears Up for Leading Role in Netflix's Blockbuster 'Perfect Dad' In an exclusive interview, Saisha Bhasin Khan shares her joy and enthusiasm...

Tiger Shroff leaves the audience amazed with his performance in ‘Bade Miyan Chote Miyan’

Tiger Shroff Stuns Audiences with His Role in 'Bade Miyan Chote Miyan ‘Bade Miyan Chote Miyan’ has been released, and people cannot stop raving about...

Map of Limitless Positivity ! Discover the Shining Spots Across the US Where Total Solar Eclipse Thrills Await

Map of Nope: Unveiling the Regions of the United States Exempt from Total Solar Eclipse Phenomena In the vast tapestry of celestial events, few occurrences...

Latest Articles